PD-1 signalling in CD4+T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced tolerance

被引:27
作者
Konkel, Joanne E. [3 ]
Frommer, Friederike [4 ]
Leech, Melanie D. [1 ,2 ,3 ]
Yagita, Hideo [5 ]
Waisman, Ari [4 ]
Anderton, Stephen M. [1 ,2 ,3 ]
机构
[1] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Univ Edinburgh, Ctr Multiple Sclerosis Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland
[3] Univ Edinburgh, Ashworth Labs, Ctr Immun Infect & Evolut, Inst Immunol & Infect Res,Sch Biol Sci, Edinburgh EH16 4TJ, Midlothian, Scotland
[4] Johannes Gutenberg Univ Mainz, Dept Med 1, D-6500 Mainz, Germany
[5] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan
基金
英国医学研究理事会; 英国惠康基金;
关键词
costimulation; T cells; tolerance; CD8(+) T-CELLS; IN-VIVO; DENDRITIC CELLS; COSTIMULATORY MOLECULE; NOD MICE; EXPRESSION; RESPONSES; PATHWAY; ANTIGEN; AUTOIMMUNITY;
D O I
10.1111/j.1365-2567.2009.03216.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>The ultimate outcome of T-cell recognition of peptide-major histocompatibility complex (MHC) complexes is determined by the molecular context in which antigen presentation is provided. The paradigm is that, after exposure to peptides presented by steady-state dendritic cells (DCs), inhibitory signals dominate, leading to the deletion and/or functional inactivation of antigen-reactive T cells. This has been utilized in a variety of models providing peptide antigen in soluble form in the absence of adjuvant. A co-inhibitory molecule of considerable current interest is PD-1. Here we show that there is the opportunity for the PD-1/PD-L1 interaction to function in inhibiting the T-cell response during tolerance induction. Using traceable CD4+ T-cell receptor (TCR) transgenic cells, together with a blocking antibody to disrupt PD-1 signalling, we explored the roles of PD-1 in the induction of tolerance versus a productive immune response. Intact PD-1 signalling played a role in limiting the extent of CD4+ T-cell accumulation in response to an immunogenic stimulus. However, PD-1 signalling was not required for either the induction, or the maintenance, of peptide-induced tolerance; a conclusion underlined by successful tolerance induction in TCR transgenic cells genetically deficient for PD-1. These observations contrast with the reported requirement for PD-1 signals in CD8+ T-cell tolerance.
引用
收藏
页码:92 / 102
页数:11
相关论文
共 39 条
[1]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[2]   Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[3]   Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis [J].
Bettelli, E ;
Pagany, M ;
Weiner, HL ;
Linington, C ;
Sobel, RA ;
Kuchroo, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1073-1081
[4]   Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses [J].
Butte, Manish J. ;
Keir, Mary E. ;
Phamduy, Theresa B. ;
Sharpe, Arlene H. ;
Freeman, Gordon J. .
IMMUNITY, 2007, 27 (01) :111-122
[5]  
Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO
[6]  
2-9
[7]   PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo [J].
Chikuma, Shunsuke ;
Terawaki, Seigo ;
Hayashi, Tamon ;
Nabeshima, Ryusuke ;
Yoshida, Takao ;
Shibayama, Shiro ;
Okazaki, Taku ;
Honjo, Tasuku .
JOURNAL OF IMMUNOLOGY, 2009, 182 (11) :6682-6689
[8]   Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways [J].
Fife, Brian T. ;
Bluestone, Jeffrey A. .
IMMUNOLOGICAL REVIEWS, 2008, 224 :166-182
[9]   Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway [J].
Fife, Brian T. ;
Guleria, Indira ;
Bupp, Melanie Gubbels ;
Eagar, Todd N. ;
Tang, Qizhi ;
Bour-Jordan, Helene ;
Yagita, Hideo ;
Azuma, Miyuki ;
Sayegh, Mohamed H. ;
Bluestone, Jeffrey A. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (12) :2737-2747
[10]   Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal [J].
Fife, Brian T. ;
Pauken, Kristen E. ;
Eagar, Todd N. ;
Obu, Takashi ;
Wu, Jenny ;
Tang, Qizhi ;
Azuma, Miyuki ;
Krummel, Matthew F. ;
Bluestone, Jeffrey A. .
NATURE IMMUNOLOGY, 2009, 10 (11) :1185-U70